Pharmagreen Biotech Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pharmagreen Biotech Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2018 to Q3 2022.
  • Pharmagreen Biotech Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2022 was $2.09M, a 8.03% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $2.09M +$155K +8.03% Sep 30, 2022 10-K 2023-01-17
Q3 2021 $1.93M +$186K +10.6% Sep 30, 2021 10-K 2023-01-17
Q3 2020 $1.74M +$243K +16.2% Sep 30, 2020 10-K 2021-12-29
Q3 2019 $1.5M +$585K +63.8% Sep 30, 2019 10-K 2021-01-08
Q3 2018 $917K Sep 30, 2018 10-K 2019-12-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.